ASRS
MRSN

Arizona State Retirement System’s Mersana Therapeutics MRSN Stock Holding History

Arizona State Retirement System’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-977
Closed -$31K – 2176
2023
Q3 		$31K Buy
977
+58
+6% +$2.76K ﹤0.01% 2166
2023
Q2 		$75.6K Sell
919
-6
-0.6% -$878 ﹤0.01% 2148
2023
Q1 		$95.1K Buy
925
+48
+5% +$6.74K ﹤0.01% 2122
2022
Q4 		$129K Buy
877
+34
+4% +$5.75K ﹤0.01% 2054
2022
Q3 		$143K Buy
843
+24
+3% +$3.9K ﹤0.01% 2011
2022
Q2 		$95K Buy
819
+197
+32% +$18.5K ﹤0.01% 2128
2022
Q1 		$62K Buy
622
+4
+0.6% +$467 ﹤0.01% 2201
2021
Q4 		$96K Buy
618
+12
+2% +$2.33K ﹤0.01% 2219
2021
Q3 		$143K Buy
606
+10
+2% +$2.92K ﹤0.01% 2137
2021
Q2 		$202K Sell
596
-42
-7% -$15.9K ﹤0.01% 2114
2021
Q1 		$258K Buy
638
+3
+0.5% +$1.46K ﹤0.01% 1897
2020
Q4 		$422K Buy
635
+18
+3% +$10K ﹤0.01% 1550
2020
Q3 		$287K Buy
617
+218
+55% +$110K ﹤0.01% 1610
2020
Q2 		$233K Buy
+399
New +$136K ﹤0.01% 1583

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Arizona State Retirement System's MRSN Position: Q4 2023 in Review

Arizona State Retirement System sold out of Mersana Therapeutics (MRSN) in Q4 2023, closing a stake of 977 shares — an estimated $31K sold.

Arizona State Retirement System first reported a position in MRSN in Q2 2020 and held it in 14 quarters. The position peaked at $422K in Q4 2020. 105 funds tracked by Wall St. Rank hold MRSN as of Q4 2023.

  • Arizona State Retirement System reported no remaining Mersana Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 977 Mersana Therapeutics shares in Q4 2023, an estimated $31K.
  • Arizona State Retirement System first reported a position in Mersana Therapeutics in Q2 2020 and held it in 14 quarters.
  • Arizona State Retirement System's Mersana Therapeutics position peaked at $422K in Q4 2020.
  • 105 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q4 2023.

Based on Arizona State Retirement System's 13F filing for Q4 2023, filed 24 Jan 2024.